Coronavirus Now: COVID-19 Updates for July 4

As of July 4, confirmed cases of COVID-19 now number at more than 11.1 million around the world, including more than 2.8 million cases in the United States and more than 131,000 U.S. deaths. You can see a breakdown of coronavirus cases throughout the world and within the U.S. on the map and chart above.

Below you’ll find updates on the latest news about the coronavirus.


July 4 News Updates

Coronavirus Cases Worldwide Now Greater than 11 Million

For the first time, coronavirus cases worldwide are now greater than 11 million. The U.S. still leads the cases with 2.89 million. Brazil follows with more than 1.54 million. Next is Russia with more than 667,000 and India with more than 649,000.

Texas Doctor Can’t Accept All ECMO Patient Requests

The number of COVID-19 hospitalizations is increasing so much in some parts of Texas that hospital beds are becoming an issue, People reported. In San Antonio, Dr. Jeffrey DellaVolpe, a pulmonologist and the director of the ECMO program, said that he had 10 calls for young people who were good candidates to be put on ECMO, but they only had three beds available. DellaVolpe said he uses the ECMO as a method to keep patients off ventilators, because: “I think the ventilator really causes a lot of harm. It causes harm in general but certainly causes harm when we’re talking about patients with COVID.”

Patients being admitted to the hospital are getting younger, he added. 

Kimberly Guilfoyle, Donald Trump Jr.’s Girlfriend, Tests Positive for Coronavirus

Kimberly Guilfoyle, Donald Trump Jr.’s girlfriend, has tested positive for coronavirus, CNN reported. She was immediately isolated and is doing well. Officials said she’s asymptomatic but her events were canceled as a precaution. Donald Trump Jr. tested negative. She hasn’t had recent contact with President Donald Trump, but she was backstage in Tulsa during the rally and she was at the Phoenix event.

Vaccine Updates

GettyA woman leaves Life Care Center of Kirkland on February 29, 2020, in Kirkland, Washington.

Moderna’s new vaccine has shown promise in early trials of eight volunteers who received two doses, The New York Times reported. The vaccine showed a safe immune response. The trial will now be repeated with hundreds and later thousands of people in a July trial. The vaccine uses mRNA from the virus, which is a new process. The earliest a Moderna vaccine might be available would be the end of this year or early 2021.

Oxford University researchers have tested a vaccine that successfully works in monkeys and is being tested in Britain volunteers, WUSA9 reported in late April. If all goes well, the first few million doses could be ready as soon as September. The vaccine uses genes from a spikey protein to help the immune system make antibodies.

Bill Gates is funding factories that will test seven vaccine candidates to help mobilize vaccines faster, Business Insider reported in early April. He said: “Even though we’ll end up picking at most two of them, we’re going to fund factories for all seven, just so that we don’t waste time.”

A second potential COVID-19 vaccine is from Inovio, called the INO-4800 DNA vaccine. Inovio completed Phase 1 trial for a similar DNA vaccine for MERS. The Bill and Melinda Gates Foundation is backing this trial. Inovio announced positive results from two Phase I clinical trials in early July. The Phase 1 trial has now been expanded to include older participants, and Phase 2/3 may begin this summer. The Phase 1 trial had 40 healthy volunteers ages 18 to 50 who had 1 mg and 2 mg cohorts, with two doses taken four weeks apart. All were safe through week 8 and only 10 had minor adverse events, mostly just redness at the injection site. Analyses showed 94% had immunological response rates. The vaccine has also been shown to protect mice, preventing viral replication in their lungs.

On March 30, Johnson & Johnson announced that it will start human clinical trials for a vaccine in September, with the first round not being available until early 2021.

A clinical vaccine trial funded by NIH at Kaiser Permanente in Washington began on Monday, March 16. Forty-five people participated in the first round. The vaccine candidate code is mRNA-1273. As of May 1, about 2/3 of the participants had gotten their first of two doses, NBC News reported.

Israeli scientists have said they may be close to a vaccine, The Jerusalem Post reported. Scientists have been working on a vaccine against a bronchial disease that affected poultry. Dr. Chen Katz told The Jerusalem Post that out of luck, they had chosen a coronavirus as the proof of concept for their technology, and the DNA of COVID-19 is very similar.

Greffex in Houston has a potential vaccine ready for animal testing, Yahoo! reported. And Walter Reed and the U.S. Army have been conducting animal studies since January.


Coronavirus Trends in the United States

An interactive map from MappingSupport.com shows recent trends in deaths per state over the last 14 and 7 days. You can view the full map here. Green means the trend is decreasing, red means the deaths are increasing. Circles show the prior 14 days and triangles show the prior seven days.


Open this map full screen.

Another map sourcing the most recent news about the virus can be found here.

If you are concerned about your symptoms, talk with your doctor right away.

READ NEXT: Best N95 Masks & Respirators to Keep You Safe